EP4406603A2 - MEDIUM CHAIN TRIGLYCERIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME, AND/OR EPILEPSY